NCT07102069View on ClinicalTrials.gov

Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia

CompletedOBSERVATIONAL
Enrollment

384

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

June 14, 2022

Study Completion Date

September 14, 2022

Conditions
Schizophrenia
Trial Locations (1)

Unknown

Tianjin Anding Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Anding Hospital

OTHER

NCT07102069 - Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia | Biotech Hunter | Biotech Hunter